Catalyst Wire Dossier Catalyst Wire Dossier

Turoctocog alfa pegol

Turoctocog alfa pegol · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Turoctocog alfa pegol, covering 2021-11-26 to 2021-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A [Phase 3]

See pricing